DocuSign, Inc. (NASDAQ:DOCU) Receives Average Rating of “Hold” from Analysts

DocuSign, Inc. (NASDAQ:DOCU) has been given an average rating of “Hold” by the fifteen ratings firms that are presently covering the stock, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and four have assigned a buy rating to the company. The average twelve-month price target among brokers that have issued a report on the stock in the last year is $95.00.

DOCU has been the subject of a number of recent research reports. Morgan Stanley lifted their price objective on DocuSign from $62.00 to $97.00 and gave the company an “equal weight” rating in a research note on Friday, December 6th. Robert W. Baird set a $93.00 target price on shares of DocuSign in a report on Friday, March 14th. HSBC reissued a “reduce” rating on shares of DocuSign in a report on Friday, December 6th. Jefferies Financial Group lifted their price objective on shares of DocuSign from $80.00 to $95.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. Finally, Wedbush reissued a “neutral” rating and set a $100.00 target price on shares of DocuSign in a research note on Friday, March 14th.

DocuSign Price Performance

NASDAQ DOCU opened at $89.39 on Wednesday. The stock’s fifty day moving average price is $87.50 and its 200 day moving average price is $80.91. DocuSign has a 1 year low of $48.70 and a 1 year high of $107.86. The company has a market cap of $18.10 billion, a price-to-earnings ratio of 18.43, a PEG ratio of 6.94 and a beta of 1.02.

DocuSign (NASDAQ:DOCU) last issued its earnings results on Thursday, March 13th. The company reported $0.86 EPS for the quarter, beating analysts’ consensus estimates of $0.84 by $0.02. DocuSign had a return on equity of 14.90% and a net margin of 34.73%. The firm had revenue of $776.25 million for the quarter, compared to analyst estimates of $760.94 million. During the same quarter in the prior year, the firm earned $0.76 earnings per share. DocuSign’s revenue for the quarter was up 9.0% on a year-over-year basis. Research analysts expect that DocuSign will post 1.17 earnings per share for the current year.

Insiders Place Their Bets

In other DocuSign news, Director Teresa Briggs sold 534 shares of the company’s stock in a transaction on Monday, March 17th. The stock was sold at an average price of $87.41, for a total transaction of $46,676.94. Following the transaction, the director now directly owns 8,270 shares in the company, valued at $722,880.70. This represents a 6.07 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider James P. Shaughnessy sold 7,500 shares of the business’s stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $90.17, for a total value of $676,275.00. Following the completion of the sale, the insider now owns 43,781 shares in the company, valued at $3,947,732.77. This represents a 14.63 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 97,851 shares of company stock valued at $8,579,369 in the last three months. 1.66% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Itau Unibanco Holding S.A. acquired a new stake in DocuSign during the 3rd quarter worth approximately $28,000. Kestra Investment Management LLC purchased a new position in DocuSign in the fourth quarter valued at $30,000. Brooklyn Investment Group acquired a new position in DocuSign during the 3rd quarter worth $33,000. Modus Advisors LLC acquired a new position in DocuSign during the 4th quarter worth $36,000. Finally, First Horizon Advisors Inc. raised its position in DocuSign by 102.6% in the 4th quarter. First Horizon Advisors Inc. now owns 397 shares of the company’s stock valued at $36,000 after purchasing an additional 201 shares in the last quarter. Hedge funds and other institutional investors own 77.64% of the company’s stock.

DocuSign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.